Technological advances to increase immunogenicity of DNA vaccines

References

• Pisetsky DS. The immunological properties of DNA. Immunol 156, 421 (1996).
   Google Scholar
• Gurunathan S, Wu CY, Freidag BL, Seder RA. DNA vaccines: a key for inducing long-term cellular immunity. G117: Opin. Immund 12(4), 442–447 (2000).
   Google Scholar
• Ulmer JB, Donnelly JJ, Parker SE et al. Heterologous protection against influenza by injection of DNA encoding a viral protein. Science 259, 1745–9 (1993).
   PubMed Web of Science ®Google Scholar
• Michel ML, Davis HL, Schleef M, Mancini M, Tiollais P, Whalen RG. DNA-mediated immunization to the hepatitis B surface antigen in mice: aspects of the humoral response mimic hepatitis B viral infection in humans. Proc. Nati Acad. Sci USA 92, 5307–11 (1995).
   PubMed Web of Science ®Google Scholar
• Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Ann. Rev Immunol. 15, 617–648 (1997).
   PubMed Web of Science ®Google Scholar
• Barouch DH et al. Control of viremia and prevention of clinical AIDS in rhesus monkeys by cytokine-augmented DNA vaccination. Science 290,486-492 (2000). Offers a good perspective on the potential of DNA vaccines. This is an illustration of their efficacy in large animals.
   Google Scholar
• Leitner WW Ying H, Restifo NP DNA and RNA-based vaccines: principles, progress and prospects. Vaccine 10, 765–777 (1999).
   Google Scholar
• Tighe H, Corr M, Roman M, Raz E. Gene vaccination: plasmid DNA is more than just a blueprint. Immunol Today19, 89–97 (1998).
   PubMedGoogle Scholar
• Feltquate D, Heaney MS, Webster RG, Robinson HL. Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization. J. Immunol. 158, 2278 (1997).
   PubMed Web of Science ®Google Scholar
• Boyle JS, Silva A, Brady JL, Lew AM. DNA immunization: induction of higher avidity antibody and effect of route on T cell cytotorricity. Pmc. Nati Acad. Li. USA 94, 14626 (1997).
   PubMed Web of Science ®Google Scholar
• Robinson HL, Torres CA. DNA vaccines. Semin. Immunol 9, 271 (1997).
   PubMedGoogle Scholar
• Yokoyama M, Hassett DE, Zhang J, Whitton JL. DNA immunization can stimulate florid local inflammation, and the antiviral immunity induced varies depending on injection site. Vaccine15, 553 (1997).
   Google Scholar
• Danko IP, Williams P, Herweijer H et al. High expression of naked plasmid DNA in muscles of young rodents. Hum. Mal Genet. 6, 1435–1443 (1997).
   Google Scholar
• Corr M, Lee DJ, Carson DA, Tighe H. Gene vaccination with naked plasmid DNA: mechanism of CTL priming. J. Exp. Med. 184, 1555 (1996).
   PubMed Web of Science ®Google Scholar
• Robinson HL, Lu S, Feltquate DM et al. DNA vaccines. AIDS Res Hum. Retroviruses. 12, 455–457 (1996).
   Google Scholar
• Raz ED, Carson DA, Parker SE et al Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc. Nati Acad. Sci. USA 91, 9519–9523 (1994).
   PubMed Web of Science ®Google Scholar
• Condon C, Watkins SC. Celluzzi CM, Thompson K, Palo LD. DNA-based immunization by in vivo transfection of dendritic cells. Nat. Merl 2, 1122 (1996).
   Google Scholar
• Torres CA, Iwasaki A, Barber BH, Robinson HL. Differential dependence on target site tissue for gene gun and intramuscular DNA immunizations. J. Immund 158(10), 4529 (1997).
   Google Scholar
• Chen Y, Hu D, Bing DJ, Robbins J, Kipps TJ. DNA vaccines encoding full-length or truncated Neu induce protective immunity against Neu-expressing mammary tumors. Cancer Res. 58(9), 1965–1971 (1998).
   Google Scholar
• Dalum I, Jensen MR, Gregorius K, Thomasen CM, Elsner HI, Mouritsen S. Induction of cross-reactive antibodies against a self protein by immunization with a modified self protein containing a foreign T helper epitope. Mal Immunol 34,1113–1120 (1997).
   PubMed Web of Science ®Google Scholar
• Xiang R. et al An autologuous oral DNA vaccine protects against murine melanoma. Proc. Natl Acad. Sci. USA. 97,5492–5497 (2001).
   Google Scholar
• Kim JJ et al Modulation of amplitude and direction of in vivo immune responses by coadministration of cytokine gene expression cassettes with DNA immunogens. Eur. j Immunol 28,1089–1093 (1998).
   Google Scholar
• Krieg AM, Yi AK, Schorr J, Davis HL. The role of CpG dinucleotides in DNA vaccines. Wends. Microbial 6,23–27 (1998).
   PubMed Web of Science ®Google Scholar
• Huang AY, Bruce AT, Pardoll DM, Levitsky HI. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo?' Exp. Med. 183,769–776 (1996).
   Google Scholar
• Bueler H, Mulligan RC. Induction of antigen-specific tumor immunity by genetic and cellular vaccines against MAGE: enhanced tumor protection by coexpression of granulocyte-macrophage colony-stimulating factor and B7-1. Mal Med 2(5), 545–555 (1996).
   Google Scholar
• Davis HL. CpG motifs for optimization of DNA vaccines. Dev.fflasel) 104,165–169 (2000).
   Google Scholar
• Leitner WW, Hammerl P, Thalhamer J. Nucleic acid for the treatment of cancer: genetic vaccines and DNA adjuvants. CUI7: Phalli?. Des. 7(16), 1641–1667 (2001).
   Google Scholar
• Stan AC, Casares S, Brumeanu TD, Klinman DM, Bona CA. CpG motifs of DNA vaccines induce the expression of chemokines and MHC class II molecules on myocytes. Eur Immunol 31(1), 301–310 (2001).
   PubMed Web of Science ®Google Scholar
• Krieg AM. CpG motifs in bacterial DNA and their immune effects. Ann. Rev Immunol 20,709–760 (2002).
   PubMed Web of Science ®Google Scholar
• ••Nice review of the new findings that CpGmotifs bind Toll-like receptors and the physiological consequences of such binding. Krieg and his team has carried out tremendous work in the CpG field.
   Google Scholar
• Gurunathan S, Klinman DM, Seder RA. DNA vaccines: immunology, application, and optimization. Ann. Rev Immunol 18, 927–974 (2000).
   Google Scholar
• ••Recommended because it really goes intodetail about several imrnunomodulatory and molecular adjuvants used to improve DNA vaccines.
   Google Scholar
• Rakhmilevich AL, Imboden M, Hao Z et al. Effective particle-mediated vaccination against mouse melanoma by coadministration of plasmid DNA encoding Gp100 and granulocyte-macrophage colony-stimulating factor. Clin. Cancer Res 7(4), 952–961 (2001).
   Google Scholar
• Scheerlinck JY. Genetic adjuvants for DNA vaccines. Vaccine 19(17-19), 2647–2656 (2001).
   PubMed Web of Science ®Google Scholar
• Moore AC, Kong WP, Chakrabarti BK, Nabel GJ. Effects of antigen and genetic adjuvants on immune responses to human immunodeficiency virus DNA vaccines in mice.j Viral 76(1), 243–250 (2002).
   PubMed Web of Science ®Google Scholar
• Parajuli P, Pisarev V, Sublet J et al Immunization with wild-type p53 gene sequences coadministered with F1t3 ligand induces an antigen-specific type 1 T-cell response. Cancer Res. 61(22), 8227–8234 (2001).
   Google Scholar
• Caux C, Vanbervliet B, Massacrier C et al. Regulation of dendritic cell recruitment by chemokines. Transplantation 73(1 Suppl.), S7-11 (2002).
   Google Scholar
• Boyer JD, Kim J, Ugen K et al. HIV-1 DNA vaccines and chemokines. Vaccine 17\(Suppl. 2), S53-64 (1999).
   Google Scholar
• Lu Y, Xin KQ, Hamajima K et al Macrophage inflammatory protein-lalpha (MIP-lalpha) expression plasmid enhances DNA vaccine-induced immune response against HIV-1. Clin. Exp. Immunol 115(2), 335-341(1999).
   Google Scholar
• Eo SK, Lee S, Kumaraguru U, Rouse BT Immunopotentiation of DNA vaccine against herpes simplex virus via codelivery of plasmid DNA expressing CCR7 ligands. Vaccine 19 (32), 4685–4693 (2001).
   Google Scholar
• Xin KQ, Lu Y, Hamajima K et al Immunization of RANTES expression plasmid with a DNA vaccine enhances HIV-1-specific immunity. Clin. Immunol 92(1), 90–96 (1999).
   Google Scholar
• Selby M, Goldbeck C, Pertile T, Walsh R, Ulmer J. Enhancement of DNA vaccine potency by electroporation in vivo. Biotechnol 83(1-2), 147–152 (2000).
   Google Scholar
• Ng KY, Liu Y. Therapeutic ultrasound: Its application in drug delivery. Med. Res. Rev 22(2), 204–223 (2002).
   Google Scholar
• Tuting T The immunology of cutaneous DNA immunization. CLI17: Opin. Mal Ther. 1(2), 216–225 (1999).
   Google Scholar
• Chen D, Erickson CA, Endres RL et al. Adjuvantation of epidermal powder immunization. Vaccine 19(20-22), 2908–2917(2001).
   PubMed Web of Science ®Google Scholar
• Denis-Mize KS, Dupuis M, MacKichan ML et al Plasmid DNA adsorbed onto cationic microparticles mediates target gene expression and antigen presentation by dendritic cells. Gene Ther 7,2105–2112 (2000).
   PubMed Web of Science ®Google Scholar
• Alakhov V Yu, Kabanov AV Block copolymers biotransport carriers as versatile vehicles for drug delivery. Exp. Opin. Invest. Drup7, 1453–1473 (1998).
   PubMedGoogle Scholar
• Astafieva I, Maksimova I, Lukanidin E et al Enhancement of the polycation-mediated DNA uptake and cell transfection with Pluronic P85 block copolymer. FEBS Lett. 389,278–280 (1996).
   PubMed Web of Science ®Google Scholar
• Nguyen HK, Lemieux P, Vinogradov SV et al Evaluation of polyether- polyethyleneimine graft copolymers as gene transfer agents. Gene Ther 7(2), 126–138 (2000).
   PubMed Web of Science ®Google Scholar
• Lemieux P, Guerin N, Paradis G et al A combination of poloxamers increases gene expression of plasmid DNA in skeletal muscle. Gene Ther 7,986–991 (2000).
   PubMed Web of Science ®Google Scholar
• Shiver et al. Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity. Nature 415(6869), 331–335 (2002).
   Google Scholar
• •Recent paper showing the limit of nonviral delivery systems, compared with adenoviral systems.
   Google Scholar
• Leifert JA, Lindencrona JA, Charo J, Whitton JL. Enhancing T cell activation and antiviral protection by introducing the HIV-1 protein transduction domain into a DNA vaccine. Hum. Gene. Ther. 12(15), 1881–1892 (2001).
   Google Scholar
• Nagata T, Higashi T, Aoshi T, Suzuki M, Uchijima M, Koide Y. Immunization with plasmid DNA encoding MHC class II binding peptide/CLIP-replaced invariant chain (Ii) induces specific helper T cells in vivo: the assessment of Ii p31 and p41 isoforms as vehicles for immunization. Vaccine20(1–2), 105–114 (2001).
   Google Scholar
• Van Bergen J, Camps M, Offringa R, Melief CJ, Ossendorp F, Koning E Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide. Cancer Res. 60(22), 6427–6433 (2000).
   Google Scholar
• Hess AD, Thobum C, Chen W, Miura Y, Van der Wall E. The N-terminal flanking region of the invariant chain peptide augments the immunogenicity of a cryptic 'self" epitope from a tumor-associated antigen. Clin. Immunol 101(1), 67–76 (2001).
   Google Scholar
• Dempsey PW, Allison ME, Akkaraju S, Goodnow CC, Fearon DT C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271(5247), 348–350 (1996).
   Google Scholar
• Ross TM, Xu Y, Green TD, Montefiori DC, Robinson HL. Enhanced avidity maturation of antibody to human immunodeficiency virus envelope: DNA vaccination with gp120-C3d fusion proteins. AIDS Res. Hum. Retroviruses 17(9), 829–835 (2001).
   Google Scholar
• Deliyannis G, Boyle JS, Brady JL, Brown LE, Lew AM. A fusion DNA vaccine that targets antigen-presenting cells increases protection from viral challenge. Proc. Nati Acad. Sc]. USA 97(12), 6676–6680 (2000).
   Google Scholar
• Suzue K, Zhou X, Eisen HN, Young RA. Heat shock fusion proteins as vehicles for antigen delivery into the major histocompatibility complex class I presentation pathway. Proc. Natl Acad. Sc]. USA. 94,13146–13151 (1997).
   PubMed Web of Science ®Google Scholar
• Planelles L, Thomas CM, Alonso CL, Lopez MC. DNA Immunization with Trypanosoma cruzi HSP70 Fused to the KMP11 Protein Elicits a Cytotoxic and Humoral Immune Response against the Antigen and Leads to Protection. Infect. Immun. 69(10), 6558–6563 (2001).
   Google Scholar
• Rice J, Elliott T, Buchan S, Stevenson FK. DNA fusion vaccine designed to induce cytotoxic T cell responses against defined peptide motifs: implications for cancer vaccines. I knmund. 167(3), 1558–1565 (2000).
   Google Scholar
• Rovero S, Boggio K, Carlo ED et al Insertion of the DNA for the 163–171 peptide of ILlbeta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Her-2/neu transgenic BALB/c mice. Getz, Then 8(6), 447–452 (2001).
   Google Scholar
• Cheng WF, Hung CF, Chai CY et al. Tumor- specific immunity and antiangiogenesis generated by a DNA vaccine encoding calreticulin linked to a tumor antigen. J. Glitz Invest 108(5), 669–678 (2001).
   PubMed Web of Science ®Google Scholar
• •Demonstrates other uses of DNA vaccine and shows the therapeutic benefits, such as the antiangiogenic activity.
   Google Scholar
• Youssef S, Maor G, Wildbaum G, Grabie N, Gour-Lavie A, Karin N. C-C chemokine-encoding DNA vaccines enhance breakdown of tolerance to their gene products and treat ongoing adjuvant arthritis. Clin. Invest. 106(3), 361–371 (2000).
   Google Scholar
• Youssef S, Wildbaum G, Karin N. Prevention of experimental autoimmune encephalomyelitis by MIP-lalpha and MCP-1 naked DNA vaccines. J. Autoimmutz 13(1), 21–29 (1999).
   Google Scholar
• Hertz M, Mahalingam S, Dalum I et al. Active vaccination against IL-5 bypasses immunological tolerance and ameliorates experimental asthma. J. Immunol 167(7), 3792–3799 (2001).
   Google Scholar
• Prudhomme GJ, Chang Y, Li X. Immunoinhibitory DNA vaccine protects against autoimmune diabetes through cDNA encoding a selective CTLA-4 (CD152) ligand. Hum. Gene Ther 13, 395–406 (2002).
   Google Scholar